Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ELDNELDN
Showing 8 of 22 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ELEDON PHARMACEUTICALS INC

NORTHERN TRUST CORP holds 616,399 shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $2.4M as of 2026-Q2. The position was increased (+13.3% shares). ELDN represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$2.4M

Current Shares

616,399

Total Value Change

+$2.2M

Total Shares Change

+524,506

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
616,399
+13.3%
$2.4M0.0%$3.94
30
2026-Q1
Increased
543,842
+26.5%
$1.7M0.0%$2.50
32
2025-Q4
Increased
429,813
+0.3%
$649,0180.0%$1.51
24
2025-Q3
Decreased
428,562
-5.6%
$1.1M0.0%$2.54
0
2025-Q2
Increased
454,077
+247.5%
$1.2M0.0%$2.69
41
2025-Q1
Increased
130,673
+3.0%
$442,9810.0%$3.35
25
2024-Q4
Increased
126,885
+38.1%
$522,7660.0%$4.14
32
2024-Q3
Unchanged
91,893
0.0%
$228,8140.0%$2.49
0

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used